Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria

Mise à jour : Il y a 4 ans
Référence : NCT00440999

Femme et Homme

Extrait

The purpose of this study is to compare the efficacy and safety of the fixed combination of pyronaridine artesunate (180:60 mg) with that of standard chloroquine therapy in children and adults with acute, uncomplicated Plasmodium vivax malaria.


Critère d'inclusion

  • Malaria


Liens